# A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS

> **NCT05279755** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **ProJenX** · enrollment: 72 (estimated)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** prosetin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT05279755
- **Lead sponsor:** ProJenX
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-02-26
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-10-31
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05279755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05279755, "A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05279755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*